• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体结构域间及共激活因子相互作用的结构基础表明核受体激活功能优势发生了转变。

Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.

作者信息

He Bin, Gampe Robert T, Kole Adam J, Hnat Andrew T, Stanley Thomas B, An Gang, Stewart Eugene L, Kalman Rebecca I, Minges John T, Wilson Elizabeth M

机构信息

Laboratories for Reproductive Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Mol Cell. 2004 Nov 5;16(3):425-38. doi: 10.1016/j.molcel.2004.09.036.

DOI:10.1016/j.molcel.2004.09.036
PMID:15525515
Abstract

The androgen receptor (AR) is required for male sex development and contributes to prostate cancer cell survival. In contrast to other nuclear receptors that bind the LXXLL motifs of coactivators, the AR ligand binding domain is preferentially engaged in an interdomain interaction with the AR FXXLF motif. Reported here are crystal structures of the ligand-activated AR ligand binding domain with and without bound FXXLF and LXXLL peptides. Key residues that establish motif binding specificity are identified through comparative structure-function and mutagenesis studies. A mechanism in prostate cancer is suggested by a functional AR mutation at a specificity-determining residue that recovers coactivator LXXLL motif binding. An activation function transition hypothesis is proposed in which an evolutionary decline in LXXLL motif binding parallels expansion and functional dominance of the NH(2)-terminal transactivation domain in the steroid receptor subfamily.

摘要

雄激素受体(AR)是男性性发育所必需的,并且有助于前列腺癌细胞的存活。与其他结合共激活因子LXXLL基序的核受体不同,AR配体结合结构域优先与AR FXXLF基序进行结构域间相互作用。本文报道了结合和未结合FXXLF及LXXLL肽的配体激活的AR配体结合结构域的晶体结构。通过比较结构功能和诱变研究确定了建立基序结合特异性的关键残基。在一个特异性决定残基处的功能性AR突变恢复了共激活因子LXXLL基序结合,这提示了前列腺癌中的一种机制。提出了一种激活功能转变假说,即LXXLL基序结合的进化性下降与类固醇受体亚家族中NH(2)-末端反式激活结构域的扩展和功能优势并行。

相似文献

1
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.雄激素受体结构域间及共激活因子相互作用的结构基础表明核受体激活功能优势发生了转变。
Mol Cell. 2004 Nov 5;16(3):425-38. doi: 10.1016/j.molcel.2004.09.036.
2
Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.通过亮氨酸/苯丙氨酸交换测定FXXLF和LXXLL基序的雄激素受体配体结合域相互作用及核受体特异性。
Mol Endocrinol. 2006 Aug;20(8):1742-55. doi: 10.1210/me.2005-0348. Epub 2006 Apr 20.
3
Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.雄激素受体AF-2(激活功能2)核心结构域的突变分析揭示了与其他核受体相比保守残基的功能和机制差异。
Mol Endocrinol. 2000 Oct;14(10):1603-17. doi: 10.1210/mend.14.10.0544.
4
Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.雄激素受体对FXXLF和LXXLL基序的不同识别模式。
Mol Endocrinol. 2004 Sep;18(9):2132-50. doi: 10.1210/me.2003-0375. Epub 2004 Jun 3.
5
Structural features discriminate androgen receptor N/C terminal and coactivator interactions.结构特征区分雄激素受体 N/C 端和共激活因子的相互作用。
Mol Cell Endocrinol. 2012 Jan 30;348(2):403-10. doi: 10.1016/j.mce.2011.03.026. Epub 2011 Jun 1.
6
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.类固醇受体招募LXXLL和FXXLF基序中的静电调制。
Mol Cell Biol. 2003 Mar;23(6):2135-50. doi: 10.1128/MCB.23.6.2135-2150.2003.
7
Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.黑色素瘤抗原基因蛋白MAGE-11通过调节结构域间相互作用来调控雄激素受体功能。
Mol Cell Biol. 2005 Feb;25(4):1238-57. doi: 10.1128/MCB.25.4.1238-1257.2005.
8
Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2.雄激素诱导的氨基末端与羧基末端相互作用通过激活功能2抑制p160共激活因子的募集。
J Biol Chem. 2001 Nov 9;276(45):42293-301. doi: 10.1074/jbc.M107492200. Epub 2001 Sep 10.
9
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.睾酮和双氢睾酮对雄激素受体激活功能2的调节作用。
J Biol Chem. 2007 Aug 31;282(35):25801-16. doi: 10.1074/jbc.M703268200. Epub 2007 Jun 25.
10
The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.雄激素受体氨基末端结构域在p160共激活因子刺激的基因转录中起关键作用。
Mol Cell Biol. 1999 Sep;19(9):6085-97. doi: 10.1128/MCB.19.9.6085.

引用本文的文献

1
The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens.从鱼类到智人,调控雄激素受体功能的真核生物线性基序的演变。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf688.
2
In-silico identification of novel inhibitors of human androgen receptors and prostrate-specific membrane antigen: a comprehensive target-based molecular docking, molecular dynamics simulation, and ADME-toxicity studies.人雄激素受体和前列腺特异性膜抗原新型抑制剂的计算机虚拟鉴定:基于靶点的全面分子对接、分子动力学模拟及ADME毒性研究
In Silico Pharmacol. 2025 Jun 13;13(2):88. doi: 10.1007/s40203-025-00375-9. eCollection 2025.
3
The androgen receptor amino-terminal domain: structure, function and therapeutic potential.
雄激素受体氨基末端结构域:结构、功能及治疗潜力
Endocr Oncol. 2025 Feb 19;5(1):e240061. doi: 10.1530/EO-24-0061. eCollection 2025 Jan.
4
Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.雄激素受体单体和二聚体调节前列腺癌细胞中相反的生物学过程。
Nat Commun. 2024 Sep 3;15(1):7675. doi: 10.1038/s41467-024-52032-y.
5
Androgen Receptor in Hormone Receptor-Positive Breast Cancer.雄激素受体在激素受体阳性乳腺癌中的作用。
Int J Mol Sci. 2023 Dec 29;25(1):476. doi: 10.3390/ijms25010476.
6
A carboxy-terminal ubiquitylation site regulates androgen receptor activity.一个羧基末端泛素化位点调节雄激素受体活性。
Commun Biol. 2024 Jan 5;7(1):25. doi: 10.1038/s42003-023-05709-x.
7
Two somatic mutations in the androgen receptor N-terminal domain are oncogenic drivers in hepatocellular carcinoma.两种雄激素受体 N 端结构域的体细胞突变是肝癌的致癌驱动因素。
Commun Biol. 2024 Jan 5;7(1):22. doi: 10.1038/s42003-023-05704-2.
8
Rational optimization of a transcription factor activation domain inhibitor.转录因子激活结构域抑制剂的合理优化。
Nat Struct Mol Biol. 2023 Dec;30(12):1958-1969. doi: 10.1038/s41594-023-01159-5. Epub 2023 Dec 4.
9
Hormone-induced enhancer assembly requires an optimal level of hormone receptor multivalent interactions.激素诱导的增强子组装需要激素受体多价相互作用的最佳水平。
Mol Cell. 2023 Oct 5;83(19):3438-3456.e12. doi: 10.1016/j.molcel.2023.08.027. Epub 2023 Sep 21.
10
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.鉴定破坏雄激素受体共激活蛋白-蛋白相互作用从而改变反式激活的变构调节剂-用于转移性去势抵抗性前列腺癌的药物先导物。
SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6.